Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23538180 | 1.00 | EGFR (0.56) | EGFRERBB2 | |
| SCHEMBL23537955 | 0.96 | EGFR (0.59) | EGFRERBB2 | |
| SCHEMBL23537942 | 0.91 | EGFR (0.67) | EGFRERBB2 | |
| SCHEMBL23537941 | 0.91 | EGFR (0.67) | EGFRERBB2 | |
| SCHEMBL23537577 | 0.90 | EGFR (0.57) | EGFRERBB2 | |
| SCHEMBL23537574 | 0.90 | EGFR (0.57) | EGFRERBB2 | |
| SCHEMBL23537790 | 0.89 | EGFR (0.70) | EGFRERBB2 | |
| SCHEMBL23537792 | 0.89 | EGFR (0.70) | EGFRERBB2 | |
| SCHEMBL23537607 | 0.88 | EGFR (0.65) | EGFRERBB2 | |
| SCHEMBL23537650 | 0.88 | EGFR (0.56) | EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021127397-A1 | NITROGEN HETEROCYCLIC COMPOUNDS AND METHODS OF USE | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021127397-A1 | NITROGEN HETEROCYCLIC COMPOUNDS AND METHODS OF USE | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |